JP Patent

JP2001508759A — 片頭痛の処置法

Assigned to Eli Lilly and Co · Expires 2001-07-03 · 25y expired

What this patent protects

(57)【要約】本発明は鎮痛用量のオランザピンを投与することを含む片頭痛の処置法を提供する。

USPTO Abstract

(57)【要約】本発明は鎮痛用量のオランザピンを投与することを含む片頭痛の処置法を提供する。

Drugs covered by this patent

lasmiditan-succinate (LASMIDITAN SUCCINATE)

Patent Metadata

Patent number: JP2001508759A
Jurisdiction: JP
Classification: —
Expires: 2001-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.